glp-1 drugs and muscle loss Some people taking weight are concerned about loss. In general, people with obesity have more muscle mass than people without obesity — simply because their bodies have to Does GLP-1 Cause Muscle Pain?
Description
Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway

Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

Regarding renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria but not on hard kidney endpoints